SWG Educational Activities

Kim de De Keersmaecker:

  • Oral presentation: New insights in ribosomal disorders, 23nd EHA Annual Congress June 13-16, 2018, Stockholm, Sweden.

Carlo Dufour:

  • Chairman of the SWG on GCMFS oral session, 23nd EHA Annual Congress June 13-16, 2018, Stockholm, Sweden.
  • Oral presentation on Immunosuppressive therapy or SCT front-line therapy, 2018 EBMT Annual Congress. Lisbon, March 19, 2018.
  • Oral presentation on Inherited marrow failure disorders, 2018 EBMT Annual Congress. Lisbon, March 19, 2018.
  • Oral presentation on URD SCT as a primary therapy for children with newly diagnosed SAA. Currently a reasonable option. 6th International Bone Marrow Failure Symposium, March 22-23, 2018, Bethesda, (MD) USA.
  • Oral presentation on Treatment of Congenital Marrow failure syndromes: state of the art, EBMT, Infectious Disease, Paediatric disease and Inborn errors. Working Parties Educational Meeting Verona, June 8, 2018.
  • Oral presentation on Transplant indications for AA and Constitutional Marrow Fail. 3rd EBMT International Transplant Course, September 7-9, 2018, Barcelona.
  • Oral presentation on Choosing between IST and AD HSCT in paediatric SAA. ISHBT- EHA Joint Symposium. 59th Annual Conference of Indian Society of Hematology and Blood Transfusion, October 25-28, 2018.
  • Oral presentation on Treatment options in Fanconi Anemia. 59th Annual Conference of Indian Society of Hematology and Blood Transfusion, October 25‑28, 2018.
  • Oral presentation on Upfront MUD transplantation in SAA. SAAWP & ADWP Joint Educational Training Course EBMT, Florence, November 15-17, 2018.

Francesca Fioredda:

  • Chairman of Granulocyte disease session at the 2018 ASH annual meeting, San Diego (CA).
  • Oral Presentation on Dyskeratosis Congenita, SAAWP & ADWP Joint Educational Training Course EBMT, November 15-17, 2018.

Cristina Mecucci:

  • Oral presentation on Acquiring the interplay of leukemia predisposition genes and marrow failures, 23nd EHA Annual Congress June 13-16, 2018, Stockholm Sweden.

Helen Papadaki:

  • Oral presentation on Myeloid modulators, 23nd EHA Annual Congress June 13‑16, 2018, Stockholm Sweden.